WASHINGTON, Oct. 16 (UPI) — A new study suggests that a sweet-tasting compound called 2DG has great potential as a treatment for epilepsy.
2DG (2-deoxy-glucose) has long been used in radio labeling, medical scanning and cancer imaging studies in humans. But now researchers at the University of Wisconsin-Madison have found the substance also blocks the onset of epileptic seizures in laboratory rats.